Ear disease
Conditions
Interventions
Group 1:Acoustic therapy combined with glucocorticoid / batroxobin versus Placebo combined with glucocorticoid / batroxobin
Sponsors
The First Affiliated Hospital of Guangzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) Subjects must voluntarily participate in the study and follow the research regulations, understand and follow the follow-up plan, accept relevant instrument examinations, and voluntarily sign written informed consent; 2) Subject aged 18-70 years old; 3) Gender is not limited, limited to Chinese; 4) The subject must be primary tinnitus, and secondary tinnitus can be used while actively treating the primary disease.
Exclusion criteria
Exclusion criteria: 1. Patients with severe cardiovascular and cerebrovascular diseases who cannot tolerate the relevant examination or treatment; 2. Have a history of mental illness, confrontation, bad motivation, suspiciousness or other emotional or intellectual problems, which may affect the informed validity of participating in the study; 3. Patients who refused to be included in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tinnitus Handicap Inventory(THI); | — |
Secondary
| Measure | Time frame |
|---|---|
| Tinnitus Handicap Questionnaire;Tinnitus Severity Index(TSI); | — |
Countries
China
Contacts
Public ContactXiaowen Zhang
The First Affiliated Hospital of Guangzhou Medical University
Outcome results
None listed